Cofepris granted emergency clearance to use the Pfizer coronavirus vaccine on Friday.
Grow your business, Not your inbox
Stay up to date and subscribe to our daily newsletter now!
2 min read
This article has been translated from our Spanish edition using AI technologies. Errors can occur due to this process.
This story originally appeared on Alto Nivel
The Undersecretary of State for Prevention and Health Promotion, Hugo López-Gatell , announced that the Pfizer-BioNTech Vaccine against the coronavirus COVID-19 received approval for emergencies from the Federal Commission for Prevention and Health Risks ( Cofepris ).
This makes Mexico the fourth country, after the UK, Bahrain and Canada, to approve Pfizer's vaccine against COVID-19.
Yesterday the USA FDA & # 39; s The Advisory Committee endorsed the drug's use of the antigen, although it has not yet been officially approved by the agency.
On Tuesday, British citizens became the first in the world to receive doses of a COVID-19 formula for which extensive clinical studies have already been conducted.
The UK Medicines Agency advised people with a significant history of allergies not to vaccinate the Pfizer BioNTech vaccine against COVID-19 after two people reported serious side effects on the first day of launch.